Rankings
▼
Calendar
PLSE Q4 2022 Earnings — Pulse Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
PLSE
Pulse Biosciences, Inc.
$1B
Q4 2022 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
-$9,000
-101.1% YoY
Gross Profit
-$1M
14444.4% margin
Operating Income
-$9M
97166.7% margin
Net Income
-$9M
102188.9% margin
EPS (Diluted)
$-0.25
QoQ Revenue Growth
-Infinity%
Cash Flow
Operating Cash Flow
-$8M
Free Cash Flow
-$8M
Stock-Based Comp.
$748,000
Balance Sheet
Total Assets
$78M
Total Liabilities
$80M
Stockholders' Equity
-$2M
Cash & Equivalents
$61M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
-$9,000
$844,000
-101.1%
Gross Profit
-$1M
-$397,000
-227.5%
Operating Income
-$9M
-$15M
+43.3%
Net Income
-$9M
-$15M
+40.3%
← FY 2022
All Quarters
Q1 2023 →